Influcid A tablets

Šalis: Armėnija

kalba: anglų

Šaltinis: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Veiklioji medžiaga:

aconitum trit.D3, gelsemium trit.D3, ipecacuanha trit.D3, phosphorus trit.D5, bryonia trit. D2, eupatorium perfoliatum trit.D1

Prieinama:

Dr. Gustav Klein GmbH & Co. KG

ATC kodas:

առկա չէ

INN (Tarptautinis Pavadinimas):

aconitum trit.D3, gelsemium trit.D3, ipecacuanha trit.D3, phosphorus trit.D5, bryonia trit. D2, eupatorium perfoliatum trit.D1

Dozė:

25mg+ 25mg+ 25mg+ 25mg+ 25mg+ 25mg

Vaisto forma:

tablets

Vienetai pakuotėje:

(40/2x20/) in blister

Recepto tipas:

OTC

Autorizacija statusas:

Registered

Leidimo data:

2022-06-10

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Influcid A
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet (250 mg) contains:
Active substances:
Aconitum trit. D3
25.0 mg
Gelsemium trit. D3
25.0 mg
Ipecacuanha trit. D3
25.0 mg
Phosphorus trit. D5
25.0 mg
Bryonia trit. D2
25.0 mg
Eupatorium perfoliatum trit.D1
25.0 mg
Excipients with known effect: lactose monohydrate, wheat starch
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment and prevention of feverish flu-like infections and other
acute viral upper respiratory tract
infections. Supportive treatment of influenza.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults and adolescents from 12 years of age _in acute conditions_,
should take in 1 tablet every hour
(but not more than 6 tablets per day). This frequency after a week of
use can only be continued after
consultation with a homeopathic experienced therapist. _With further
improvement_, adults and
adolescents over 12 years old should take 1 tablet 1-3 times a day.
_ _
_Paediatric population _
Children aged 1 to 6 years: _in acute conditions_, should not receive
more than half of adult dose (3
tablets per day). For small children under 6 years of age, it is
advisable to resolve the tablet before
taking into a small amount of water.
Children aged 6-12 years should not receive more than 2/3 of adult
dose (4 tablets per day).
Method of administration
Tablets should be allowed to dissolve slowly in the mouth. For young
children, tablets can be
dissolved in a little bit of water.
An interval of at least half an hour to meals should be kept.
3
4.3
CONTRAINDICATIONS
Hypersensitivity to Eupatorium perfoliatum (common boneset) or other
members of the
asteraceae/compositae family, any other of the active substances or to
any of the excipients listed in
section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
This medicinal product contains lactose and wheat starch. Patients
with rare hereditary